Novartis | NOVN - Market Capitalization


Novartis reported $248.1B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
J&J USD 595.26B 16.1B Jul/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 248.1B 59.65B Jul/2026
Novartis USD 319.89B 31.63B Jul/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Orion EUR 8.28B 1.86B Jul/2026
Pfizer USD 153.81B 12.24B Mar/2026
Philips EUR 22.47B 96.29M Mar/2026
Recordati EUR 10.26B 104.56M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025